Amnion Life is a leading brand in the medical device industry, specializing in products that aim to increase the survivability and thrivability of preterm infants. With a focus on improving the chances of survival, reducing long-term health issues, and decreasing the time spent in neonatal intensive care, Amnion Life offers innovative solutions to address the challenges faced by premature babies. Their flagship product, the AmnioBed™, is a revolutionary proprietary MedTech device designed to regulate the temperature of infants immediately after birth.

By replacing traditional methods such as radiant warmers and plastic wraps, the AmnioBed™ ensures optimal temperature control, reducing the risk of hypothermia and related complications. Alongside the AmnioBed™, Amnion Life also offers the AmnioBed™ 24Hour, a solution for use in the neonatal intensive care unit. This device improves temperature regulation, fluid management, and skin protection, ultimately increasing weight gain and minimizing short-term and long-term complications.

Additionally, Amnion Life has developed the Artificial Placenta, a patented extracorporeal membrane oxygenation and nutrition machine. This device provides oxygen support for infants with underdeveloped lungs, connecting to the umbilical vessels upon cutting the cord. Amnion Life is committed to research and development, with a state-of-the-art facility dedicated to the production and refinement of their products.

They have also secured a robust intellectual property portfolio, including multiple patents and trademarks. By combining innovative technology, rigorous research, and a commitment to improving the lives of preterm infants, Amnion Life is at the forefront of advancing neonatal care and ensuring a brighter future for premature babies and their families